These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6832093)

  • 21. Lack of bladder tumor promoting activity in rats fed sodium saccharin in AIN-76A diet.
    Okamura T; Garland EM; Masui T; Sakata T; St John M; Cohen SM
    Cancer Res; 1991 Apr; 51(7):1778-82. PubMed ID: 2004361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A general probabilistic model of carcinogenesis: analysis of experimental urinary bladder cancer.
    Greenfield RE; Ellwein LB; Cohen SM
    Carcinogenesis; 1984 Apr; 5(4):437-45. PubMed ID: 6705147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of 1-2-dimethylhydrazine-induced bowel carcinogenesis by the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Steele G; Chrissey M; Gittes R; Corson J; Wilson R
    Carcinogenesis; 1980 Feb; 1(2):135-8. PubMed ID: 22282992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB; Sonda LP; Lesser ML
    Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Light and scanning electron microscopy of exfoliated bladder epithelial cells in rats fed N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
    Jacobs JB; Arai M; Cohen SM; Friedell GH
    J Natl Cancer Inst; 1976 Jul; 57(1):63-6. PubMed ID: 1003508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced immunoreactivity of ras oncogene p21 protein in urinary bladder epithelium of rats treated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Masui T; Ward JM; Cohen SM
    Cancer Lett; 1991 Aug; 59(2):95-102. PubMed ID: 1884376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
    Cohen SM; Wittenberg JF; Bryan GT
    Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of L-tryptophan excess and vitamin B6 deficiency on rat urinary bladder cancer promotion.
    Birt DF; Julius AD; Hasegawa R; St John M; Cohen SM
    Cancer Res; 1987 Mar; 47(5):1244-50. PubMed ID: 3815336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of sodium salts of phenobarbital and barbital on development of bladder tumors in male F344/NCr rats pretreated with either N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-nitrosobutyl-4-hydroxybutylamine.
    Diwan BA; Hagiwara A; Ward JM; Rice JM
    Toxicol Appl Pharmacol; 1989 Apr; 98(2):269-77. PubMed ID: 2711390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early induction of mouse urinary bladder ornithine decarboxylase activity by rodent vesical carcinogens.
    Matsushima M; Bryan GT
    Cancer Res; 1980 Jun; 40(6):1897-901. PubMed ID: 7371022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early lesions in experimental bladder cancer: experimental design and light microscopic findings.
    Cohen SM; Jacobs JB; Arai M; Johansson S; Friedell GH
    Cancer Res; 1976 Jul; 36(7 PT 2):2508-11. PubMed ID: 1277158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of promoters on incidence of bladder cancer in experimental animal models.
    Hicks RM
    Environ Health Perspect; 1983 Apr; 50():37-49. PubMed ID: 6873029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity of urine of various species fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or 2-amino-4-(5-nitro-2-furyl)thiazole.
    Hayashida S; Wang CY
    Mutat Res; 1984 Mar; 135(3):169-73. PubMed ID: 6369128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    LaVoie EJ; Shigematsu A; Rivenson A; Mu B; Hoffmann D
    J Natl Cancer Inst; 1985 Dec; 75(6):1075-81. PubMed ID: 3865011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of antipyrene on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced urinary tract carcinogenesis.
    Johansson SL; Anderström C
    Carcinogenesis; 1988 May; 9(5):783-7. PubMed ID: 3365839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Wang CY; Hayashida S; Pamukcu AM; Bryan GT
    Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
    Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB
    Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Hosaka Y; Muramatsu M; Matsushima T; Niijima T; Nagase S
    Jpn J Cancer Res; 1985 Jul; 76(7):577-82. PubMed ID: 3928553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Cohen SM; Murasaki G; Fukushima S; Greenfield RE
    Cancer Res; 1982 Jan; 42(1):65-71. PubMed ID: 7053869
    [No Abstract]   [Full Text] [Related]  

  • 40. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo.
    Mann AM; Asamoto M; Chlapowski FJ; Masui T; Macatee TL; Cohen SM
    Carcinogenesis; 1992 Sep; 13(9):1651-5. PubMed ID: 1394851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.